Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood

Mary M. Lee, Patricia K. Donahoe, Tomonobu Hasegawa, Bernard Silverman, Gretchen B. Crist, Sharon Best, Yukihiro Hasegawa, Richard A. Noto, David Schoenfeld, David T. MacLaughlin

Research output: Contribution to journalArticle

351 Citations (Scopus)

Abstract

Mullerian inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.

Original languageEnglish
Pages (from-to)571-576
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume81
Issue number2
DOIs
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Anti-Mullerian Hormone
Testis
Gonadal Disorders
Tumors
Tissue
Gonadal Hormones
Sertoli Cells
Granulosa Cells
Puberty
Tumor Biomarkers
Ovary
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Mullerian inhibiting substance in humans : Normal levels from infancy to adulthood. / Lee, Mary M.; Donahoe, Patricia K.; Hasegawa, Tomonobu; Silverman, Bernard; Crist, Gretchen B.; Best, Sharon; Hasegawa, Yukihiro; Noto, Richard A.; Schoenfeld, David; MacLaughlin, David T.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 81, No. 2, 1996, p. 571-576.

Research output: Contribution to journalArticle

Lee, MM, Donahoe, PK, Hasegawa, T, Silverman, B, Crist, GB, Best, S, Hasegawa, Y, Noto, RA, Schoenfeld, D & MacLaughlin, DT 1996, 'Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood', Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 2, pp. 571-576. https://doi.org/10.1210/jc.81.2.571
Lee, Mary M. ; Donahoe, Patricia K. ; Hasegawa, Tomonobu ; Silverman, Bernard ; Crist, Gretchen B. ; Best, Sharon ; Hasegawa, Yukihiro ; Noto, Richard A. ; Schoenfeld, David ; MacLaughlin, David T. / Mullerian inhibiting substance in humans : Normal levels from infancy to adulthood. In: Journal of Clinical Endocrinology and Metabolism. 1996 ; Vol. 81, No. 2. pp. 571-576.
@article{375c14315a88447c9edd9a6a723215e3,
title = "Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood",
abstract = "Mullerian inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.",
author = "Lee, {Mary M.} and Donahoe, {Patricia K.} and Tomonobu Hasegawa and Bernard Silverman and Crist, {Gretchen B.} and Sharon Best and Yukihiro Hasegawa and Noto, {Richard A.} and David Schoenfeld and MacLaughlin, {David T.}",
year = "1996",
doi = "10.1210/jc.81.2.571",
language = "English",
volume = "81",
pages = "571--576",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Mullerian inhibiting substance in humans

T2 - Normal levels from infancy to adulthood

AU - Lee, Mary M.

AU - Donahoe, Patricia K.

AU - Hasegawa, Tomonobu

AU - Silverman, Bernard

AU - Crist, Gretchen B.

AU - Best, Sharon

AU - Hasegawa, Yukihiro

AU - Noto, Richard A.

AU - Schoenfeld, David

AU - MacLaughlin, David T.

PY - 1996

Y1 - 1996

N2 - Mullerian inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.

AB - Mullerian inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.

UR - http://www.scopus.com/inward/record.url?scp=9044238435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044238435&partnerID=8YFLogxK

U2 - 10.1210/jc.81.2.571

DO - 10.1210/jc.81.2.571

M3 - Article

C2 - 8636269

AN - SCOPUS:9044238435

VL - 81

SP - 571

EP - 576

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -